Original Research

Published on 22 Sep 2023

Optimizing tylosin dosage for co-infection of Actinobacillus pleuropneumoniae and Pasteurella multocida in pigs using pharmacokinetic/pharmacodynamic modeling

Eon-Bee Lee
Muhammad Aleem Abbas
Jonghyun Park
Dereje D. Tassew
Seung-Chun Park

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1258403

519 views

Original Research

Accepted on 18 Sep 2023

Impact of selective reporting of antimicrobial susceptibility testing report on clinicians' prescribing behavior of antibiotics

Ying Wang
Xinping Zhang
Qian Zhou
Xiaojun Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1225531

Review

Accepted on 18 Sep 2023

Exploring nanocomposites for controlling infectious microorganisms: Charting the path forward in antimicrobial strategies

Adline Princy Solomon
Harish Saravanan
Tarunkarthick Subramani
Shobana Rajaramon
HELMA DAVID
ANUSREE SAJEEVAN
Swathi Sujith

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1282073

Editorial

Published on 18 Sep 2023

Editorial: Re-emergence of neglected tropical diseases amid the COVID-19 pandemic: epidemiology, transmission, mitigation strategies, and recent advances in chemotherapy and vaccines

Ranjan K. Mohapatra
Venkataramana Kandi
Veronique Seidel
Ali A. Rabaan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1265803

580 views

Brief Research Report

Accepted on 15 Sep 2023

Analysis of Drug Resistance in Pulmonary Tuberculosis Patients with Positive Sputum Tuberculosis Culture in Northeast China

Li Sichen
Wang Rui
Yang Yue
Liu Xin
Cui Youbin
Tang Ze
Hongfei Cai

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1263726

Review

Published on 06 Sep 2023

Recent insights about pyrrolidine core skeletons in pharmacology

Samet Poyraz
H. Ali Döndaş
Naciye Yaktubay Döndaş
José M. Sansano

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1239658

728 views

Review

Published on 05 Sep 2023

Treatment of non-tuberculosis mycobacteria skin infections

Xin-Yu Wang
Qian-Nan Jia
Jun Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1242156

685 views

Perspective

Published on 24 Aug 2023

Efficacy and safety evaluation of Azvudine in the prospective treatment of COVID-19 based on four phase III clinical trials

Ke-Wei Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1228548

933 views

Original Research

Published on 15 Aug 2023

Bryum billardieri Schwaegr. against EV71 infection: in vitro and in vivo antiviral effects, identification of molecular mechanisms and active monomers

Yun-Yu Wang
Qian Li
Xiu-Wei Han
Xin-Huan Wan
Li Zhang
Feng-Jv Niu
Yi-Zhou Xin
Chang-Zheng Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1164784

552 views

Original Research

Published on 08 Aug 2023

Evaluation of the effect of direct-acting antiviral agents on melatonin level and lipid peroxidation in chronic hepatitis C patients

Nageh Ahmed El-Mahdy
Sabry Abou-Saif
Medhat Ismail Abd EL hamid
Heba M. Hashem
Mohamed Anwar Hammad
Sally El-Sayed Abu-Risha

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1128016

599 views

Review

Published on 31 Jul 2023

The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19

Binbin Xia
Li Zheng
Yali Li
Wenfang Sun
Yang Liu
Liushui Li
Jingyao Pang
Jing Chen
Jiaxin Li
Hua Cheng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1098972

659 views

Review

Published on 27 Jul 2023

Navigating drug repurposing for Chagas disease: advances, challenges, and opportunities

Exequiel O. J. Porta
Karunakaran Kalesh
Patrick G. Steel

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1233253

1,449 views

Review

Published on 26 Jul 2023

Individualized antibiotic dosage regimens for patients with augmented renal clearance

A-Xi Shi
Qiang Qu
Hai-Hui Zhuang
Xin-Qi Teng
Wei-Xin Xu
Yi-Ping Liu
Yi-Wen Xiao
Jian Qu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1137975

2,142 views

Perspective

Published on 19 Jul 2023

Effectiveness of vonoprazan-based regimens compared with proton pump inhibitor-based regimens as first-line Helicobacter pylori agents

Toshihiko Kakiuchi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1216433

784 views

Brief Research Report

Published on 18 Jul 2023

Can BioSAXS detect ultrastructural changes of antifungal compounds in Candida albicans?–an exploratory study

Kai Hilpert
Christoph Rumancev
Jurnorain Gani
Dominic W. P. Collis
Paula Matilde Lopez-Perez
Vasil M. Garamus
Ralf Mikut
Axel Rosenhahn

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1141785

798 views

Editorial

Published on 13 Jul 2023

Editorial: Global excellence in pharmacology of infectious diseases: Australia and Asia

Kwang-sun Kim

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1243284

595 views

Navigation group

Articles

Optimizing tylosin dosage for co-infection of Actinobacillus pleuropneumoniae and Pasteurella multocida in pigs using pharmacokinetic/pharmacodynamic modeling

Impact of selective reporting of antimicrobial susceptibility testing report on clinicians' prescribing behavior of antibiotics

Exploring nanocomposites for controlling infectious microorganisms: Charting the path forward in antimicrobial strategies

Editorial: Re-emergence of neglected tropical diseases amid the COVID-19 pandemic: epidemiology, transmission, mitigation strategies, and recent advances in chemotherapy and vaccines

Analysis of Drug Resistance in Pulmonary Tuberculosis Patients with Positive Sputum Tuberculosis Culture in Northeast China

Recent insights about pyrrolidine core skeletons in pharmacology

Treatment of non-tuberculosis mycobacteria skin infections

Efficacy and safety evaluation of Azvudine in the prospective treatment of COVID-19 based on four phase III clinical trials

Bryum billardieri Schwaegr. against EV71 infection: in vitro and in vivo antiviral effects, identification of molecular mechanisms and active monomers

Evaluation of the effect of direct-acting antiviral agents on melatonin level and lipid peroxidation in chronic hepatitis C patients

The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19

Navigating drug repurposing for Chagas disease: advances, challenges, and opportunities

Individualized antibiotic dosage regimens for patients with augmented renal clearance

Effectiveness of vonoprazan-based regimens compared with proton pump inhibitor-based regimens as first-line Helicobacter pylori agents

Can BioSAXS detect ultrastructural changes of antifungal compounds in Candida albicans?–an exploratory study

Editorial: Global excellence in pharmacology of infectious diseases: Australia and Asia